Dear Sen-Jam Community,

We’re on a mission to stop inflammation at its root—and improve healthspan for billions worldwide.

This week, RFK Jr.’s health adviser, Calley Means, called chronic inflammation the core failure of modern medicine and demanded innovation.

Sen-Jam is that innovation.

• Driven by AI and backed by Science, IP, KVK Tech, and Operational Excellence
• Phase 2-completed for SJP-002C and ready with SJP-001
• 1,100+ investors strong
• Built to return capital to investors via licensing & Fractional Royalty Rights
• In full alignment with the national health movement

Every investment from this final push goes directly toward funding our Phase 2 clinical trial for SJP-001—our lead therapeutic targeting inflammation caused by alcohol (and a gateway to treating much broader inflammatory conditions).

💥 With 1 day left this is your moment to invest in a company that’s ahead of the curve—and built for impact.

👉 Invest now on Wefunder

👉 Want to chat? Book a time with me HERE

Let’s finish strong.

— Jim & The Sen-Jam Team